Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine PET Imaging of HNSCC
NCT05322135Phase 1Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2022
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Standardized Uptake Value. Started Sep 2022; status: terminated.
Beyond the preview
Go deeper on NCT05322135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05322135.